In mouse fetal liver, hepatoblasts, sinusoidal endothelial cells and macrophages (or erythroblastic islands) promote differentiation and proliferation of hematopoietic cells through cell-cell interactions and secretion of cytokines and extracellular matrix factors. Until now, we have had little knowledge of the hematopoietic cytokines or extracellular matrix mRNAs expressed in hepatic stellate cells. Using p75 neurotrophin receptor (p75NTR) to mark this cell population, we sorted 12.5, 14.5 and 16.5 dpc hepatic stellate cells and analyzed expression of cytokines and extracellular matrix mRNAs. Among cytokines, insulin-like growth factor 2 (Igf2) was highly expressed at all three stages analyzed. The extracellular matrix molecule fibronectin (Fn1) was highly expressed in 12.5 dpc cells, whereas vitronectin (Vtn) was highly expressed in 14.5 and 16.5 dpc hepatic stellate cells. Among liver cells, Igf2 was predominantly expressed in hepatoblast-like cells at all three stages examined, suggesting that hepatoblast-like cells are an essential part of the niche that maintains homeostasis of hematopoietic cells in embryonic mouse liver. Defining these expression patterns could facilitate our understanding of cross talk between cytokine and extracellular matrix molecules in hepatic stellate cells and benefit research in developmental hematopoiesis as well as the study of liver biology.
Introduction
Fetal liver is a hematopoietic organ where primitive hematopoiesis ends and definitive hematopoiesis begins, making it a major site for expansion and differentiation of hematopoietic stem and progenitor cells (HSPC) before migration to bone marrow. Liver parenchymal cells are derived from the anterior portion of the definitive endoderm, which itself is established during gastrulation (Douarin 1975) . At early stages of liver development, the epithelium is made up of bipotent hepatoblasts, which subsequently differentiate into hepatocytes and cholangiocytes. Cells in the septum transversum mesenchyme trapped between growing hepatoblasts and sinusoidal endothelial cells at 10.5 days postcoitum (dpc) likely give rise to hepatic stellate cells in the liver bud (Enzan et al. 1997; Asahina et al. 2009 ). Although, in mouse, hematopoiesis begins in the yolk sac at 7.5 dpc, it is not until mid-gestation that hematopoiesis occurs in fetal liver (Johnson & Jones 1973; Johnson & Moore 1975; Medvinsky & Dzierzak 1998; Sugiyama et al. 2011a ), beginning at 10 dpc, and the liver becomes the predominant hematopoietic site by 11.5 dpc (Dzierzak & Medvinsky 1995) . Between 12.5 and 16.5 dpc, definitive hematopoietic stem cells of the liver undergo self-renewal, expand, and differentiate into hematopoietic progenitor cells (Kieusseian et al. 2012) .
Fetal liver is comprised of mature hematopoietic cells, hepatoblasts (hepatocyte progenitors), sinusoidal endothelial cells, macrophages (erythroblast islands), hepatic stellate cells and stromal fibroblasts. Those cells express a range of hematopoietic cytokines and extracellular matrix molecules and form the niche for fetal liver hematopoiesis. Hepatoblasts express the hematopoietic cytokines FMS-like tyrosine kinase 3 ligand (Flt3l), interleukin-6 (Il-6), stem cell factor (Scf) (or kit ligand (Kitl)), thrombopoietin (Thpo) and erythropoietin (Epo). Protein delta homologue 1 (DLK-1) is a marker of hepatoblasts in mouse fetal liver. DLK-1+ cells express hepatocyte-specific marker a-fetoprotein and albumin (Tanimizu et al. 2003; Nierhoff et al. 2005) . Previously, our group used DLK-1 as a marker to isolate and characterize hepatoblast in mouse fetal liver (Sugiyama et al. 2011b (Sugiyama et al. , 2013 . Mice lacking the tyrosine kinase Map2k4 fail to form hepatoblasts, resulting in decreased levels of SCF and EPO proteins and impaired hematopoiesis, suggesting that SCF and EPO regulate fetal liver hematopoiesis (Sugiyama et al. 2011b) . The extracellular matrix molecules laminin-a1 (Lama1), laminin B1 (Lamb1), laminin-b2 (Lamb2), laminin-b3 (Lamb3), laminin-c1 (Lamc1), vitronectin (Vtn), fibronectin (Fn1) and tenascin (Tnc) are expressed at higher levels in hepatoblasts than in sinusoid endothelial or hematopoietic cells (Sugiyama et al. 2013) . Production of extracellular matrix molecules is stimulated by transforming growth factor (TGF)-beta-1, which is expressed on hepatoblasts, sinusoid endothelial cells and hematopoietic cells (Sugiyama et al. 2013) . Fetal liver erythroblastic island macrophages express VCAM-1, whereas primitive erythroid cells express a4b1-integrin (Isern et al. 2008) .
Fetal hepatic stellate cells appear at 10-11 dpc, possess intracellular lipid droplets and lack vitamin A storage (Nitou et al. 2000) . The fact that they lack vitamin A storage makes it impractical to isolate these cells from fetal liver. In adult liver, these cells appeared to be vitamin A-specific autofluorescence when excited with UV light using flow cytometry (Matsumoto et al. 1984; Kubota et al. 2007) . Several groups have attempted to identify hepatic stellate cells surface markers. Using desmin, some have distinguished hepatic stellate cells from hepatoblasts and hepatocytes based on morphology and gene expression (Kiassov et al. 1995; Nitou et al. 2000) . In mouse fetal liver, the p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily, is expressed on a subset of desmin-positive cells (Asahina et al. 2009) . A previous study showed that hepatic stellate deficient in p75NTR did not differentiate into myofibroblasts in vivo, suggesting that p75NTR regulates differentiation of these cells in a way that supports hepatocyte proliferation in diseased liver (Passino et al. 2007) . Culture of 11.5 dpc p75NTR-positive liver cells on gelatin-coated or noncoated plastic dishes in the presence of oncostatin M can induce expression of glial fibrillary acidic protein, a quiescence marker for hepatic stellate cells; and alphasmooth muscle actin (a-SMA), a marker for activated hepatic stellate cells, suggesting that p75NTR marks hepatic stellate cells and perivascular mesenchymal cells (Suzuki et al. 2008) .
In rat, fetal hepatic stellate cells expressing desmin and nestin were in close contact with hematopoietic cells expressing GATA1, suggesting their roles in supporting hematopoiesis (Kordes et al. 2013) . The rat fetal hepatic stellate cells expressed genes of Csf3, Csf2, Csf1, Il3, Il6 and Epo. However, in mice, it still remains unclear whether the fetal hepatic stellate cells express genes encoding hematopoietic cytokines and extracellular matrix, which likely support hematopoiesis. Here, using p75NTR as a marker of hepatic stellate cells, we characterized embryonic mouse liver cells at 12.5, 14.5 and 16.5 dpc by cell sorting and assessed expression of cytokines and extracellular matrix mRNAs in hepatic stellate cells at those same time points using quantitative realtime PCR.
Results

Characterization of fetal liver cells
To investigate which cell type is predominant in 12.5, 14.5 and 16.5 dpc liver, we carried out flow cytometry using the DLK-1 to mark DLK-1-expressing cells or hepatoblast-like cells (Tanimizu et al. 2003) , the common leukocyte cell marker CD45, the erythroid cell marker Ter119 (Kina et al. 2000) , platelet endothelial cell adhesion molecule 1 (PECAM-1 or CD31) and lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) to mark endothelial cells of blood vessels and capillaries (Mouta Carreira et al. 2001) , and the p75NTR to mark hepatic stellate cells in sinusoids (Suzuki et al. 2008) . To characterize the purified hepatic stellate cells, we sorted out p75NTR+ cells by flow cytometry and examined expression of the following genes: (i) mesenchymal markers (vimentin and a-SMA), (ii) hepatic stellate cells transcription factors (Foxf1 and Lhx2) and (iii) hepatoblast markers (a-fetoprotein) using real-time PCR. Figure S1 in Supporting Information shows the DLK-1-Ter119-CD45-CD31-LYVE-1-p75NT R+ cells express vimentin, a-SMA, Foxf1, Lhx2 but not a-fetoprotein. Figure 1A shows the flow cytometry gating strategy used to analyze fetal liver cells at 14.5 dpc. Fractions of DLK-1-expressing cells, myeloid cell lineage, erythroid cell lineage, endothelial cells, microvessels, hepatic stellate cells and unclassified cells were sorted from 12.5, 14.5 and 16.5 dpc liver based on expression of the above-mentioned surface markers (Fig. 1B) . The proportion of cells of different lineage at each stage is shown in Table 1 . Among hematopoietic cells, the percentage of the erythroid cell lineage was higher than the myeloid cell lineage in liver cells at all three stages. In nonhematopoietic cells, however, the percentage of unclassified cells was higher than that of other liver cells such as the DLK-1 expressing cells, microvessels, endothelial cells or hepatic stellate cells at all three stages.
Expression of cytokine mRNAs in hepatic stellate cells in mid-embryogenesis
To investigate whether 12.5, 14.5 or 16.5 dpc hepatic stellate cells express cytokine mRNAs, we undertook real-time PCR using primers targeting a variety of cytokine transcripts. Cells at 12.5 dpc expressed Thpo (thrombopoietin), Epo (erythropoietin), Kitl (kit ligand), Il11 (interleukin-11), Osm (oncostatin M), Flt3l (FMS-like tyrosine kinase 3 ligand), Csf1 (colony-stimulating factor 1), Csf3 (colony-stimulating factor 3), Igf1 (insulin-like growth factor 1), and Igf2 (insulin-like growth factor 2) but did not express Il3 (interleukin-3), Il6 (interleukin-6) or Csf2 (colony-stimulating factor) ( Fig. 2A) . Cells at 14.5 dpc expressed Thpo, Kitl, Il11, Osm, Flt3l, Csf1, Igf1, and Igf2 but not Epo, Il3, Il6, Csf2 or Csf3 (Fig. 2B) . Finally, cells at 16.5 dpc expressed Thpo, Epo, Kitl, Il6, Il11, Osm, Flt3l, Csf1, Igf1, and Igf2 but not Il3, Csf2 or Csf3 (Fig. 2C) . Interestingly, expression of Igf2 mRNA was highest among cytokine mRNAs in hepatic stellate cells at all three stages examined. From 12.5 dpc until 16.5 dpc, Csf1, Kitl, Igf1, Flt3l and Osm expression was highest in 14.5 dpc hepatic stellate cells compared to 12.5 and 16.5 dpc (Fig. 3) . Igf2 and Thpo expression increased over the period from 12.5 to 16.5 dpc in hepatic stellate cells (Fig. 3) . Epo mRNA was detected in 12.5 and 16.5 dpc hepatic stellate cells but not in 14.5 dpc cells (Fig. 3) . Figure 2 Expression of cytokine mRNAs in embryonic DLK-1-CD45-Ter119-CD31-LYVE-1-p75NTR+ cells in mouse liver. Relative expression of mRNAs encoding cytokines in (A) 12.5 dpc, (B) 14.5 dpc and (C) 16.5 dpc DLK-1-CD45-Ter119-CD31-LYVE-1-p75NTR+ cells of mouse liver. Evaluated were Thpo (thrombopoietin); Epo (erythropoietin); Kitl (kit ligand); Il3 (interleukin-3); Il6 (interleukin-6); Il11 (interleukin-11); Osm (oncostatin M); Flt3l (FMS-like tyrosine kinase 3 ligand); Csf1 (colony-stimulating factor 1); Csf2 (colony-stimulating factor 2); Csf3 (colony-stimulating factor 3); Igf1 (insulin-like growth factor 1); and Igf2 (insulin-like growth factor 2). Il11 served as a baseline reference value. The comparative Ct method was used to analyze data, and results are expressed as the mean AE standard deviation.
Expression of extracellular matrix mRNAs in hepatic stellate cells in mid-embryogenesis
We next assessed expression of several extracellular matrix mRNAs in hepatic stellate cells at three different embryonic stages. At stages 12.5, 14.5 and 16.5 dpc, hepatic stellate cells expressed Fn1 (Fibronectin), Vtn (Vitronectin), Tnc (Tenascin), Lama1 (Laminin-a1), Lama2 (Laminin-a2), Lamb1-1 (Laminin-b1-1), Lamb2 (Laminin-b2), Lamc1 (Laminin-c1) and Lamc3 (Laminin-c3) but not Lamc3 (Laminin-c3) ( Fig. 4A-C) . Fn1 mRNA was highly expressed in 12.5 dpc hepatic stellate cells relative to other extracellular matrix molecules (Fig. 4A) . In 14.5 and 16.5 dpc hepatic stellate cells, Vtn mRNA was more highly expressed than other extracellular matrix molecules (Fig. 4B,C) . Over the period from 12.5 to 16.5 dpc, expression of Lama1, Tnc, Lamb2, Lamb1-1, Lama2 and Lamc1 mRNAs in hepatic stellate cells was highest in 14.5 dpc cells (Fig. 5) . Expression of Vtn, Lamc3 and Fn1 mRNAs in hepatic stellate cells increased over the entire period observed (Fig. 3 ).
Discussion
Using p75NTR as a marker to identify hepatic stellate cells in 12.5, 14.5 and 16.5 dpc mouse embryos, we also carried out flow cytometry with different markers at the same embryonic stages to isolate various liver cells of other lineages. Hepatic stellate cells were sorted and assessed for expression of cytokines and extracellular matrix mRNAs. As shown in Fig. 1A , fetal liver cells were comprised of several populations: DLK-1-expressing cells or hepatoblast-like cells, cells of the myeloid lineage, erythroid cell lineage, microvessels, endothelial cells, hepatic stellate cells, and unclassified cells, all of which regulate differentiation and proliferation in the niche (Zhang & Lodish 2004; Sugiyama et al. 2011b Sugiyama et al. , 2013 Tan et al. 2015) . Unclassified cells remain the major nonhematopoietic liver cell from 12.5 dpc until 16.5 dpc, and their number is evidence for heterogeneity of this population. Hence, additional markers are required to characterize these cells. 12.5 dpc14.5 dpc16.5 dpc
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Osm Figure 3 Comparison of expression of cytokine mRNAs across various embryonic stages in DLK-1-CD45-Ter119-CD31-LYVE-1-p75NTR+ cells of mouse liver. Evaluated were Csf1 (colony-stimulating factor 1); Igf2 (insulin-like growth factor 2); Thpo (thrombopoietin); Kitl (kit ligand); Epo (erythropoietin); Igf1 (insulin-like growth factor 1); Il11 (interleukin-11); Flt3l (FMSlike tyrosine kinase 3 ligand); and Osm (oncostatin M). Expression of each mRNA at 12.5 dpc served as a baseline reference value. The comparative Ct method was used to analyze data, and results are expressed as the mean AE standard deviation.
Hematopoiesis is regulated by soluble and membrane-bound factors, but little is known of how cytokines and extracellular matrix proteins interact in liver hematopoiesis. Kordes's group showed that mouse hematopoietic cells were maintained by coculturing with rat fetal hepatic stellate cells (2013) . In this study, expression of Igf2 mRNA was the highest among cytokine genes in mouse hepatic stellate cells at all three stages examined. Igf2 reportedly increased the number of HSPCs in vitro (Zhang & Lodish 2004) . Taken together, hepatic stellate cells likely function as hematopoietic niche through Igf2 secretion. IGF2 is expressed in long-term hematopoietic stem cells and produced by 15 dpc Ter119-CD3+ fetal liver cells (Zhang & Lodish 2004; Thomas et al. 2016) . Culturing hematopoietic stem cells with IGF2 increases the number of both multilineage colonies and hematopoietic stem cells (Zhang & Lodish 2004; Thomas et al. 2016) . We also found that 12.5, 14.5 and 16.5 dpc liver hepatoblast-like cells highly express Igf2 mRNA (Figs S2-S4 in Supporting Information). The expression of Igf2 mRNA is no difference across these embryonic stages (Fig. S5 in Supporting Information). Igf2 binds Igf1, Igf2 and insulin receptors. At 15 dpc, Igf2 reportedly binds to Igf2 receptor and insulin receptor of mouse fetal liver HSPCs and support their expansion (Zhang & Lodish 2004) . In fetal spleen at 16.5 dpc, our group also reported that erythroid cells express Igf1 receptor (Tan et al. 2015) .
In mouse, others have shown by immunostaining that fibronectin, a matrix glycoprotein functioning in attachment of hematopoietic cells to bone marrow stroma, is consistently expressed in fetal liver from 12 dpc until 0 days postpartum (van der Sluijs et al. 2011). a6-integrin is laminin receptor that likely takes part in homing of fetal liver HSPCs (Qian et al. 2007) . Previously, we reported that a6-integrin is expressed in HSPCs in mouse fetal liver at 14.5 dpc (Sugiyama et al. 2013) . At preliver stage at 9.5-10.5 dpc, HSPCs in yolk sac and AGM express CD41, which reportedly binds to vitronectin (Coller 1990; Shattil et al. 1998; Ferkowicz et al. 2003) . At 11.5 dpc, AGM-derived HSPCs start to migrate to fetal liver. We reported that vitronectin was predominantly expressed in fetal liver at 12.5 and 14.5 dpc (Sugiyama et al. 2013) . In this study, vitronectin was highly expressed in 14.5 and 16.5 dpc hepatic stellate cells, implying that vitronectin secreted from hepatic stellate cells regulate homing of HSPCs to fetal liver. When mouse hematopoietic stem cells are cultured on fibronectin-and laminin-coated plates, the number of progenitor stem cells (c-kit low Sca-1 + population) and the engraftibility of bone marrow are enhanced (Sagar et al. 2006 ).
In conclusion, hepatic stellate cells, although they are found in low numbers among fetal liver cells, express a range of hematopoietic cytokines and extracellular matrix mRNAs that likely create a niche for liver hematopoiesis.
Experimental procedures
Mice ICR mice were purchased from Nihon SLC (Hamamatsu, Japan). Noon on the day of the plug was considered 0.5 dpc. Animals were handled according to Guidelines for Laboratory Animals of Kyushu University, and the study was approved by the Animal Care and Use Committee, Kyushu University (Approval ID: A27-201-0).
Sample preparation
Fetal livers at 12.5, 14.5 and 16.5 dpc were dissected. To prepare single-cell suspensions, livers were incubated with Lamb1-1 Lama2 Lamc1 Figure 5 Comparison of expression of extracellular matrix mRNAs at various embryonic stages in DLK-1-CD45-Ter119-CD31-LYVE-1-p75NTR+ cells of mouse liver. Evaluated were Vtn (vitronectin); Lamc3 (laminin-c3); Lama1 (laminin-a1); Fn1 (fibronectin); Tnc (tenascin); Lamb2 (laminin-b2); Lamb1-1 (laminin-b1-1); Lama2 (laminin-a2); and Lamc1 (laminin-c1). Expression at 12.5 dpc served as a baseline reference value. The comparative Ct method was used to analyze data, and results are expressed as the mean AE standard deviation.
2 mg/mL collagenase type 1 (Worthington Biochemical Corporation, Lakewood, NJ, USA) in medium supplemented with 10% fetal bovine serum for 10-15 min at 37°C and passed through 100-lm nylon cell strainers (BD Biosciences, Franklin Lakes, NJ, USA).
Flow cytometry and cell sorting
Antibodies used for flow cytometry were: FITC-conjugated anti-mouse DLK-1 (MBL, Nagoya, Japan); APC-Cy7-conjugated anti-mouse Ter119 (BioLegend, San Diego, CA, USA); Pacific Blue-conjugated anti-mouse CD45 (BioLegend); PECy7-conjugated anti-mouse CD31 (BioLegend); and APCconjugated anti-mouse LYVE-1 (eBioscience, San Diego, CA, USA). Anti-mouse p75NTR monoclonal antibody (MBL) was labeled using a Biotin Labeling Kit-NH2 (Dojindo Laboratories, Kumamoto, Japan) and then further labeled using PE conjugated-Streptavidin (BioLegend) for analysis. Flow cytometric analysis and cell sorting were carried out using an FACSAria SORP cell sorter (BDIS, San Jose, CA, USA). Data files were analyzed using FLOWJO software (Tree Star, Inc., San Carlos, CA, USA).
RNA extraction and real-time PCR analysis
Total RNA of sorted cells was isolated using the RNAqueous â -Micro Kit (Ambion Inc., Austin, TX, USA)
and an RNAqueous â -4PCR kit (Ambion Inc.). mRNA was reverse transcribed using a high-capacity RNA-to-cDNA kit (Life Technologies, Carlsbad, CA, USA). cDNA was preamplified using TaqMan â PreAmp Master Mix Kit (Ambion Inc.). Gene expression levels were measured by StepOnePlus TM real-time PCR (Life Technologies). b-actin served as internal control. All primers and probes used in the study came from TaqMan â Gene Expression Assays (Life Technologies). The thermal protocol used for PCR was 2 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 s at 95°C and 1 min at 60°C. Analyses were carried out in triplicate; mRNA levels were normalized to b-actin and comparative expression (2 ÀDDCt ) was compared with a reference sample.
Statistical analysis
Data are calculated using Microsoft Excel and expressed as the mean AE standard deviation (SD) in all analyses.
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